| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein decrotonylase activity | 3.05e-08 | 5 | 30 | 3 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 3.05e-08 | 5 | 30 | 3 | GO:0160009 | |
| GeneOntologyMolecularFunction | protein de-2-hydroxyisobutyrylase activity | 2.18e-06 | 2 | 30 | 2 | GO:0160010 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 6.06e-06 | 24 | 30 | 3 | GO:0004407 | |
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 6.54e-06 | 3 | 30 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 6.88e-06 | 25 | 30 | 3 | GO:0033558 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 2.11e-05 | 36 | 30 | 3 | GO:0051059 | |
| GeneOntologyMolecularFunction | deacetylase activity | 2.91e-05 | 40 | 30 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 9.40e-05 | 59 | 30 | 3 | GO:0001222 | |
| GeneOntologyMolecularFunction | pore-forming activity | 9.75e-05 | 10 | 30 | 2 | GO:0140911 | |
| GeneOntologyMolecularFunction | collagen binding | 2.41e-04 | 81 | 30 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 2.41e-04 | 81 | 30 | 3 | GO:0016811 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.65e-04 | 229 | 30 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.19e-03 | 140 | 30 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.35e-03 | 146 | 30 | 3 | GO:0016810 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.37e-03 | 147 | 30 | 3 | GO:0042826 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.98e-03 | 167 | 30 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.34e-03 | 417 | 30 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 4.54e-03 | 67 | 30 | 2 | GO:0031492 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.89e-03 | 83 | 30 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 9.15e-03 | 875 | 30 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | nucleosome binding | 9.48e-03 | 98 | 30 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.07e-02 | 582 | 30 | 4 | GO:0140297 | |
| GeneOntologyBiologicalProcess | fungiform papilla formation | 1.58e-05 | 4 | 34 | 2 | GO:0061198 | |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 2.16e-05 | 33 | 34 | 3 | GO:2000273 | |
| GeneOntologyBiologicalProcess | disruption of plasma membrane integrity in another organism | 3.94e-05 | 6 | 34 | 2 | GO:0051673 | |
| GeneOntologyBiologicalProcess | hair follicle placode formation | 3.94e-05 | 6 | 34 | 2 | GO:0060789 | |
| GeneOntologyBiologicalProcess | fungiform papilla morphogenesis | 3.94e-05 | 6 | 34 | 2 | GO:0061197 | |
| GeneOntologyBiologicalProcess | disruption of cellular anatomical structure in another organism | 3.94e-05 | 6 | 34 | 2 | GO:0140975 | |
| GeneOntologyBiologicalProcess | fungiform papilla development | 5.51e-05 | 7 | 34 | 2 | GO:0061196 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 6.31e-05 | 47 | 34 | 3 | GO:0006476 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 7.19e-05 | 136 | 34 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | response to bacterium | 9.51e-05 | 916 | 34 | 8 | GO:0009617 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 9.89e-05 | 464 | 34 | 6 | GO:0032496 | |
| GeneOntologyBiologicalProcess | protein deacylation | 1.19e-04 | 58 | 34 | 3 | GO:0035601 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.19e-04 | 155 | 34 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 1.35e-04 | 491 | 34 | 6 | GO:0002237 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 1.52e-04 | 63 | 34 | 3 | GO:0098732 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.55e-04 | 166 | 34 | 4 | GO:0098773 | |
| GeneOntologyBiologicalProcess | tongue morphogenesis | 1.72e-04 | 12 | 34 | 2 | GO:0043587 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 1.99e-04 | 69 | 34 | 3 | GO:0042531 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 2.55e-04 | 75 | 34 | 3 | GO:0032922 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 2.77e-04 | 193 | 34 | 4 | GO:0050731 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 3.12e-04 | 16 | 34 | 2 | GO:0071697 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 3.12e-04 | 16 | 34 | 2 | GO:0061029 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 3.12e-04 | 16 | 34 | 2 | GO:0060788 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.29e-04 | 202 | 34 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of tyrosine phosphorylation of STAT protein | 3.69e-04 | 85 | 34 | 3 | GO:0042509 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 3.75e-04 | 381 | 34 | 5 | GO:0048545 | |
| GeneOntologyBiologicalProcess | response to lipid | 3.91e-04 | 1126 | 34 | 8 | GO:0033993 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 3.97e-04 | 18 | 34 | 2 | GO:0071696 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 4.15e-04 | 605 | 34 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 4.36e-04 | 90 | 34 | 3 | GO:0007260 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 4.60e-04 | 870 | 34 | 7 | GO:0030855 | |
| GeneOntologyBiologicalProcess | epithelium development | 4.73e-04 | 1469 | 34 | 9 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of MHC class II biosynthetic process | 5.43e-04 | 21 | 34 | 2 | GO:0045346 | |
| GeneOntologyBiologicalProcess | negative regulation of myotube differentiation | 5.43e-04 | 21 | 34 | 2 | GO:0010832 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 5.60e-04 | 416 | 34 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | MHC class II biosynthetic process | 5.97e-04 | 22 | 34 | 2 | GO:0045342 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 6.20e-04 | 239 | 34 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.70e-04 | 244 | 34 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | response to reactive oxygen species | 6.91e-04 | 246 | 34 | 4 | GO:0000302 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 7.12e-04 | 248 | 34 | 4 | GO:0007623 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 8.25e-04 | 112 | 34 | 3 | GO:0140888 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 8.36e-04 | 26 | 34 | 2 | GO:1902455 | |
| GeneOntologyBiologicalProcess | type II interferon-mediated signaling pathway | 9.02e-04 | 27 | 34 | 2 | GO:0060333 | |
| GeneOntologyBiologicalProcess | tongue development | 9.02e-04 | 27 | 34 | 2 | GO:0043586 | |
| GeneOntologyBiologicalProcess | defense response to Gram-negative bacterium | 9.83e-04 | 119 | 34 | 3 | GO:0050829 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 1.00e-03 | 272 | 34 | 4 | GO:0050730 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 1.04e-03 | 29 | 34 | 2 | GO:0042659 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | 1.05e-03 | 478 | 34 | 5 | GO:0006979 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.06e-03 | 724 | 34 | 6 | GO:0001934 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.08e-03 | 123 | 34 | 3 | GO:0001942 | |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.11e-03 | 30 | 34 | 2 | GO:0002227 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.16e-03 | 126 | 34 | 3 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.16e-03 | 126 | 34 | 3 | GO:0022405 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway | 1.19e-03 | 127 | 34 | 3 | GO:2001243 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 1.26e-03 | 748 | 34 | 6 | GO:0071396 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 1.30e-03 | 131 | 34 | 3 | GO:0010469 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.38e-03 | 1048 | 34 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | positive regulation of oligodendrocyte differentiation | 1.43e-03 | 34 | 34 | 2 | GO:0048714 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell proliferation | 1.51e-03 | 138 | 34 | 3 | GO:0048661 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 1.56e-03 | 780 | 34 | 6 | GO:0042327 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.58e-03 | 525 | 34 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | innate immune response | 1.75e-03 | 1092 | 34 | 7 | GO:0045087 | |
| GeneOntologyBiologicalProcess | cellular response to lipopolysaccharide | 1.79e-03 | 318 | 34 | 4 | GO:0071222 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 1.84e-03 | 148 | 34 | 3 | GO:0032963 | |
| GeneOntologyBiologicalProcess | molting cycle | 1.91e-03 | 150 | 34 | 3 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 1.91e-03 | 150 | 34 | 3 | GO:0042633 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 1.98e-03 | 327 | 34 | 4 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 2.02e-03 | 329 | 34 | 4 | GO:0018212 | |
| GeneOntologyBiologicalProcess | muscle cell proliferation | 2.02e-03 | 329 | 34 | 4 | GO:0033002 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 2.06e-03 | 154 | 34 | 3 | GO:0090090 | |
| GeneOntologyBiologicalProcess | cellular response to molecule of bacterial origin | 2.09e-03 | 332 | 34 | 4 | GO:0071219 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 2.38e-03 | 344 | 34 | 4 | GO:0060070 | |
| GeneOntologyBiologicalProcess | response to antibiotic | 2.39e-03 | 44 | 34 | 2 | GO:0046677 | |
| GeneOntologyBiologicalProcess | myotube differentiation | 2.46e-03 | 164 | 34 | 3 | GO:0014902 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | 2.51e-03 | 165 | 34 | 3 | GO:0032652 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | 2.77e-03 | 171 | 34 | 3 | GO:0032612 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.79e-03 | 1186 | 34 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | rhythmic process | 2.80e-03 | 360 | 34 | 4 | GO:0048511 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway | 2.83e-03 | 361 | 34 | 4 | GO:0097193 | |
| GeneOntologyBiologicalProcess | mucosal immune response | 2.84e-03 | 48 | 34 | 2 | GO:0002385 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 2.85e-03 | 879 | 34 | 6 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 2.85e-03 | 879 | 34 | 6 | GO:0010562 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.90e-03 | 1194 | 34 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 2.91e-03 | 364 | 34 | 4 | GO:0071216 | |
| GeneOntologyBiologicalProcess | cellular response to reactive oxygen species | 3.11e-03 | 178 | 34 | 3 | GO:0034614 | |
| GeneOntologyBiologicalProcess | skin development | 3.18e-03 | 373 | 34 | 4 | GO:0043588 | |
| GeneOntologyCellularComponent | site of polarized growth | 5.21e-05 | 253 | 34 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | secretory granule lumen | 1.69e-04 | 325 | 34 | 5 | GO:0034774 | |
| GeneOntologyCellularComponent | secretory granule | 1.75e-04 | 1014 | 34 | 8 | GO:0030141 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.82e-04 | 330 | 34 | 5 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.87e-04 | 332 | 34 | 5 | GO:0031983 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.90e-04 | 530 | 34 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 2.24e-04 | 185 | 34 | 4 | GO:0101002 | |
| GeneOntologyCellularComponent | CHD-type complex | 3.44e-04 | 17 | 34 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 3.44e-04 | 17 | 34 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.54e-04 | 85 | 34 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | transcription repressor complex | 3.80e-04 | 87 | 34 | 3 | GO:0017053 | |
| GeneOntologyCellularComponent | midbody | 4.47e-04 | 222 | 34 | 4 | GO:0030496 | |
| GeneOntologyCellularComponent | Sin3-type complex | 5.81e-04 | 22 | 34 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.93e-04 | 656 | 34 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.02e-04 | 658 | 34 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | growth cone | 6.48e-04 | 245 | 34 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | secretory vesicle | 7.03e-04 | 1246 | 34 | 8 | GO:0099503 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.07e-03 | 124 | 34 | 3 | GO:1904813 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.42e-03 | 137 | 34 | 3 | GO:0019897 | |
| GeneOntologyCellularComponent | vacuole | 3.22e-03 | 913 | 34 | 6 | GO:0005773 | |
| GeneOntologyCellularComponent | distal axon | 5.23e-03 | 435 | 34 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 5.31e-03 | 67 | 34 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 6.12e-03 | 230 | 34 | 3 | GO:0019898 | |
| Domain | His_deacetylse_1 | 2.20e-08 | 4 | 34 | 3 | IPR003084 | |
| Domain | His_deacetylse_dom | 9.00e-07 | 11 | 34 | 3 | IPR023801 | |
| Domain | Hist_deacetyl | 9.00e-07 | 11 | 34 | 3 | PF00850 | |
| Domain | - | 9.00e-07 | 11 | 34 | 3 | 3.40.800.20 | |
| Domain | His_deacetylse | 9.00e-07 | 11 | 34 | 3 | IPR000286 | |
| Domain | Defensin_propep | 3.21e-05 | 5 | 34 | 2 | PF00879 | |
| Domain | PHR | 3.21e-05 | 5 | 34 | 2 | PF08005 | |
| Domain | Alpha-defensin_pro | 3.21e-05 | 5 | 34 | 2 | IPR016327 | |
| Domain | PHR | 3.21e-05 | 5 | 34 | 2 | IPR012983 | |
| Domain | DEFENSIN | 3.21e-05 | 5 | 34 | 2 | PS00269 | |
| Domain | Alpha-defensin | 3.21e-05 | 5 | 34 | 2 | IPR006081 | |
| Domain | Defensin_propep | 3.21e-05 | 5 | 34 | 2 | IPR002366 | |
| Domain | Defensin_1 | 3.21e-05 | 5 | 34 | 2 | PF00323 | |
| Domain | Defensin_beta/alpha | 8.95e-05 | 8 | 34 | 2 | IPR006080 | |
| Domain | DEFSN | 8.95e-05 | 8 | 34 | 2 | SM00048 | |
| Domain | Hemopexin_CS | 4.30e-04 | 17 | 34 | 2 | IPR018486 | |
| Domain | Hemopexin-like_dom | 7.95e-04 | 23 | 34 | 2 | IPR000585 | |
| Domain | Hemopexin | 7.95e-04 | 23 | 34 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 7.95e-04 | 23 | 34 | 2 | PS00024 | |
| Domain | - | 7.95e-04 | 23 | 34 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 7.95e-04 | 23 | 34 | 2 | PS51642 | |
| Domain | Hemopexin-like_repeat | 7.95e-04 | 23 | 34 | 2 | IPR018487 | |
| Domain | HX | 7.95e-04 | 23 | 34 | 2 | SM00120 | |
| Domain | BACK | 5.33e-03 | 60 | 34 | 2 | SM00875 | |
| Domain | BACK | 5.50e-03 | 61 | 34 | 2 | PF07707 | |
| Domain | BACK | 5.50e-03 | 61 | 34 | 2 | IPR011705 | |
| Pathway | REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1 | 1.11e-07 | 6 | 26 | 3 | M27072 | |
| Pathway | KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION | 9.10e-07 | 11 | 26 | 3 | M47438 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 9.10e-07 | 11 | 26 | 3 | M42523 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.41e-05 | 26 | 26 | 3 | M2499 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.77e-05 | 28 | 26 | 3 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 2.19e-05 | 30 | 26 | 3 | M42517 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 2.42e-05 | 31 | 26 | 3 | M39714 | |
| Pathway | REACTOME_DEFENSINS | 2.42e-05 | 31 | 26 | 3 | MM14568 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.67e-05 | 32 | 26 | 3 | M39521 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.67e-05 | 32 | 26 | 3 | M27900 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 3.26e-05 | 5 | 26 | 2 | MM15874 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.69e-05 | 532 | 26 | 7 | M27870 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION | 6.83e-05 | 7 | 26 | 2 | M47673 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.12e-05 | 418 | 26 | 6 | MM15587 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.12e-05 | 48 | 26 | 3 | M611 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.17e-04 | 1128 | 26 | 9 | M1036 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.22e-04 | 272 | 26 | 5 | M29619 | |
| Pathway | REACTOME_DEFENSINS | 1.23e-04 | 53 | 26 | 3 | M557 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.46e-04 | 10 | 26 | 2 | M26955 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.61e-04 | 58 | 26 | 3 | M29616 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.78e-04 | 11 | 26 | 2 | MM14569 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.87e-04 | 61 | 26 | 3 | M39540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.87e-04 | 61 | 26 | 3 | M27811 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 1.90e-04 | 478 | 26 | 6 | M27620 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 2.06e-04 | 63 | 26 | 3 | M27862 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.36e-04 | 66 | 26 | 3 | M101 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 2.52e-04 | 13 | 26 | 2 | M29766 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 2.73e-04 | 511 | 26 | 6 | MM15330 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 2.81e-04 | 70 | 26 | 3 | MM15332 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 2.94e-04 | 14 | 26 | 2 | M22025 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.31e-04 | 74 | 26 | 3 | M616 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.72e-04 | 77 | 26 | 3 | MM15934 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.16e-04 | 80 | 26 | 3 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 4.37e-04 | 17 | 26 | 2 | MM14790 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 4.48e-04 | 82 | 26 | 3 | MM15922 | |
| Pathway | WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS | 4.91e-04 | 18 | 26 | 2 | M39825 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.91e-04 | 18 | 26 | 2 | M5290 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 4.91e-04 | 18 | 26 | 2 | M27901 | |
| Pathway | WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS | 6.09e-04 | 20 | 26 | 2 | M48330 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 6.68e-04 | 94 | 26 | 3 | M27230 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 7.32e-04 | 97 | 26 | 3 | MM15926 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 7.32e-04 | 97 | 26 | 3 | M9400 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 7.54e-04 | 98 | 26 | 3 | M27627 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.08e-04 | 23 | 26 | 2 | MM14954 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 8.23e-04 | 101 | 26 | 3 | M39448 | |
| Pathway | PID_IL3_PATHWAY | 1.03e-03 | 26 | 26 | 2 | M182 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.05e-03 | 110 | 26 | 3 | M48259 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES | 1.12e-03 | 27 | 26 | 2 | M47941 | |
| Pathway | REACTOME_HEMOSTASIS | 1.23e-03 | 679 | 26 | 6 | M8395 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.38e-03 | 30 | 26 | 2 | M207 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.38e-03 | 30 | 26 | 2 | M27637 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 1.38e-03 | 30 | 26 | 2 | M27941 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 1.47e-03 | 31 | 26 | 2 | M48258 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.71e-03 | 995 | 26 | 7 | MM14661 | |
| Pathway | WP_FATTY_ACID_BETAOXIDATION | 1.77e-03 | 34 | 26 | 2 | M39596 | |
| Pathway | WP_FATTY_ACID_BETAOXIDATION | 1.77e-03 | 34 | 26 | 2 | MM15937 | |
| Pathway | REACTOME_PTEN_REGULATION | 2.07e-03 | 139 | 26 | 3 | M27646 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 2.09e-03 | 37 | 26 | 2 | M39756 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.09e-03 | 37 | 26 | 2 | MM14564 | |
| Pathway | WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING | 2.69e-03 | 42 | 26 | 2 | M39452 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 2.76e-03 | 154 | 26 | 3 | M27697 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 2.76e-03 | 154 | 26 | 3 | M39007 | |
| Pathway | WP_IL6_SIGNALING | 2.82e-03 | 43 | 26 | 2 | M39656 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.82e-03 | 43 | 26 | 2 | M508 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.08e-03 | 45 | 26 | 2 | M39571 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.22e-03 | 46 | 26 | 2 | M198 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.22e-03 | 46 | 26 | 2 | MM15971 | |
| Pathway | WP_IL26_SIGNALING | 3.36e-03 | 47 | 26 | 2 | M48074 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.36e-03 | 47 | 26 | 2 | M7946 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 3.36e-03 | 47 | 26 | 2 | M1095 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 3.50e-03 | 48 | 26 | 2 | M219 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.50e-03 | 48 | 26 | 2 | M288 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 3.65e-03 | 170 | 26 | 3 | M941 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.79e-03 | 50 | 26 | 2 | M48087 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.79e-03 | 50 | 26 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.25e-03 | 53 | 26 | 2 | MM14566 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 4.57e-03 | 55 | 26 | 2 | MM14932 | |
| Pathway | PID_FGF_PATHWAY | 4.57e-03 | 55 | 26 | 2 | M276 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 4.84e-03 | 188 | 26 | 3 | MM15828 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.60e-03 | 61 | 26 | 2 | M27103 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 5.83e-03 | 201 | 26 | 3 | M39605 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 5.96e-03 | 63 | 26 | 2 | M254 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 6.15e-03 | 64 | 26 | 2 | M26953 | |
| Pathway | PID_RB_1PATHWAY | 6.34e-03 | 65 | 26 | 2 | M279 | |
| Pathway | WP_AGERAGE_PATHWAY | 6.53e-03 | 66 | 26 | 2 | M39420 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 6.53e-03 | 66 | 26 | 2 | M27938 | |
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. | 8.54e-10 | 3 | 34 | 3 | 19099586 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 18212746 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 20731616 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23087373 | ||
| Pubmed | Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. | 8.54e-10 | 3 | 34 | 3 | 24821725 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 18501342 | ||
| Pubmed | HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. | 8.54e-10 | 3 | 34 | 3 | 27342975 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 21972094 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 33670166 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 30279482 | ||
| Pubmed | HDAC1/2 and HDAC3 play distinct roles in controlling adult Meibomian gland homeostasis. | 8.54e-10 | 3 | 34 | 3 | 38679196 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 33637599 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 18347167 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 11358320 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23475113 | ||
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma. | 8.54e-10 | 3 | 34 | 3 | 20415600 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 9346952 | ||
| Pubmed | Histone deacetylases specifically down-regulate p53-dependent gene activation. | 3.41e-09 | 4 | 34 | 3 | 10777477 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 33907245 | ||
| Pubmed | Class I HDAC activity is required for renal protection and regeneration after acute kidney injury. | 3.41e-09 | 4 | 34 | 3 | 24808536 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 17311813 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 11259576 | ||
| Pubmed | Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. | 3.41e-09 | 4 | 34 | 3 | 12393887 | |
| Pubmed | Class I histone deacetylase activity is required for proliferation of renal epithelial cells. | 3.41e-09 | 4 | 34 | 3 | 23698124 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 19912635 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 26283270 | ||
| Pubmed | Expression profile of class I histone deacetylases in human cancer tissues. | 3.41e-09 | 4 | 34 | 3 | 17786334 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 15051733 | ||
| Pubmed | Expression of class I histone deacetylases during chick and mouse development. | 3.41e-09 | 4 | 34 | 3 | 20979029 | |
| Pubmed | Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. | 8.52e-09 | 5 | 34 | 3 | 10669754 | |
| Pubmed | Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. | 8.52e-09 | 5 | 34 | 3 | 27420561 | |
| Pubmed | GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma. | 8.52e-09 | 5 | 34 | 3 | 29453984 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 22641068 | ||
| Pubmed | Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies. | 8.52e-09 | 5 | 34 | 3 | 26447190 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 20097764 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 10581039 | ||
| Pubmed | Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. | 8.52e-09 | 5 | 34 | 3 | 21143702 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 24939842 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 12972430 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 27012186 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 23624624 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 20473547 | ||
| Pubmed | LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. | 8.52e-09 | 5 | 34 | 3 | 17785205 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 28497810 | ||
| Pubmed | Identification and mapping of human histone acetylation modifier gene homologues. | 8.52e-09 | 5 | 34 | 3 | 9722949 | |
| Pubmed | HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. | 8.52e-09 | 5 | 34 | 3 | 31097476 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 33601056 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 19015268 | ||
| Pubmed | Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. | 8.52e-09 | 5 | 34 | 3 | 17245431 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 15713663 | ||
| Pubmed | Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1. | 8.52e-09 | 5 | 34 | 3 | 18439917 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 21685935 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 10490602 | ||
| Pubmed | Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. | 1.70e-08 | 6 | 34 | 3 | 15927959 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 11641274 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 11788710 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 11777905 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 26679995 | ||
| Pubmed | Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. | 1.70e-08 | 6 | 34 | 3 | 14633989 | |
| Pubmed | Control of the cell cycle by neurotrophins: lessons from the p75 neurotrophin receptor. | 1.70e-08 | 6 | 34 | 3 | 12371150 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 18245468 | ||
| Pubmed | The balance between acetylation and deacetylation controls Smad7 stability. | 1.70e-08 | 6 | 34 | 3 | 15831498 | |
| Pubmed | SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. | 1.70e-08 | 6 | 34 | 3 | 16820529 | |
| Pubmed | Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. | 1.70e-08 | 6 | 34 | 3 | 11302704 | |
| Pubmed | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. | 1.70e-08 | 6 | 34 | 3 | 15653507 | |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 2.98e-08 | 7 | 34 | 3 | 16481466 | |
| Pubmed | Class I histone deacetylases in retinal progenitors and differentiating ganglion cells. | 2.98e-08 | 7 | 34 | 3 | 30179675 | |
| Pubmed | Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. | 2.98e-08 | 7 | 34 | 3 | 19995069 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 15467736 | ||
| Pubmed | A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. | 2.98e-08 | 7 | 34 | 3 | 19081374 | |
| Pubmed | Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. | 2.98e-08 | 7 | 34 | 3 | 17182846 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 11867749 | ||
| Pubmed | Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. | 2.98e-08 | 7 | 34 | 3 | 12419806 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 18241676 | ||
| Pubmed | Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. | 2.98e-08 | 7 | 34 | 3 | 17956988 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 11022042 | ||
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 11804585 | ||
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 22308472 | ||
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 27068467 | ||
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 11533236 | ||
| Pubmed | Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. | 4.76e-08 | 8 | 34 | 3 | 20663877 | |
| Pubmed | Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. | 4.76e-08 | 8 | 34 | 3 | 12032080 | |
| Pubmed | Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. | 4.76e-08 | 8 | 34 | 3 | 16288017 | |
| Pubmed | Identification of a nuclear domain with deacetylase activity. | 7.14e-08 | 9 | 34 | 3 | 10984530 | |
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 11641275 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 16537907 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 18241125 | ||
| Pubmed | Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. | 7.14e-08 | 9 | 34 | 3 | 11466315 | |
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 15367668 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 26221039 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 22989952 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 19463978 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 19244234 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 11923873 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 12711221 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 28028172 | ||
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 1.02e-07 | 10 | 34 | 3 | 15619633 | |
| Pubmed | 1.87e-07 | 12 | 34 | 3 | 24722339 | ||
| Pubmed | 1.87e-07 | 12 | 34 | 3 | 15140878 | ||
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 3.08e-07 | 14 | 34 | 3 | 12015313 | |
| Interaction | OVOL1 interactions | 9.55e-07 | 12 | 34 | 3 | int:OVOL1 | |
| Interaction | ARID4A interactions | 6.77e-06 | 73 | 34 | 4 | int:ARID4A | |
| Interaction | TKFC interactions | 1.77e-05 | 93 | 34 | 4 | int:TKFC | |
| Interaction | SAP30L interactions | 2.31e-05 | 33 | 34 | 3 | int:SAP30L | |
| Interaction | C22orf31 interactions | 2.75e-05 | 5 | 34 | 2 | int:C22orf31 | |
| Interaction | TNFSF10 interactions | 2.77e-05 | 35 | 34 | 3 | int:TNFSF10 | |
| Interaction | MAFK interactions | 3.28e-05 | 37 | 34 | 3 | int:MAFK | |
| Interaction | NR2E1 interactions | 3.55e-05 | 38 | 34 | 3 | int:NR2E1 | |
| Interaction | DEFA3 interactions | 4.13e-05 | 6 | 34 | 2 | int:DEFA3 | |
| Interaction | ZNF521 interactions | 4.48e-05 | 41 | 34 | 3 | int:ZNF521 | |
| Interaction | JDP2 interactions | 4.81e-05 | 42 | 34 | 3 | int:JDP2 | |
| Interaction | SNAI3 interactions | 7.69e-05 | 8 | 34 | 2 | int:SNAI3 | |
| Interaction | HR interactions | 8.15e-05 | 50 | 34 | 3 | int:HR | |
| Interaction | PRDM4 interactions | 9.16e-05 | 52 | 34 | 3 | int:PRDM4 | |
| Interaction | NRP2 interactions | 1.34e-04 | 59 | 34 | 3 | int:NRP2 | |
| Interaction | INSM1 interactions | 1.51e-04 | 11 | 34 | 2 | int:INSM1 | |
| Interaction | SMYD1 interactions | 1.55e-04 | 62 | 34 | 3 | int:SMYD1 | |
| Interaction | SPI1 interactions | 1.95e-04 | 67 | 34 | 3 | int:SPI1 | |
| Interaction | DTX3L interactions | 2.04e-04 | 68 | 34 | 3 | int:DTX3L | |
| Interaction | TBX3 interactions | 2.13e-04 | 69 | 34 | 3 | int:TBX3 | |
| Interaction | H2AC1 interactions | 2.32e-04 | 71 | 34 | 3 | int:H2AC1 | |
| Interaction | APPL1 interactions | 2.41e-04 | 182 | 34 | 4 | int:APPL1 | |
| Interaction | CCDC71 interactions | 2.42e-04 | 72 | 34 | 3 | int:CCDC71 | |
| Interaction | BCL11B interactions | 2.62e-04 | 74 | 34 | 3 | int:BCL11B | |
| Interaction | PPP4R1 interactions | 2.84e-04 | 76 | 34 | 3 | int:PPP4R1 | |
| Interaction | HDAC9 interactions | 3.06e-04 | 78 | 34 | 3 | int:HDAC9 | |
| Interaction | CBFA2T3 interactions | 3.06e-04 | 78 | 34 | 3 | int:CBFA2T3 | |
| Interaction | FRY interactions | 3.27e-04 | 16 | 34 | 2 | int:FRY | |
| Interaction | CCN5 interactions | 3.27e-04 | 16 | 34 | 2 | int:CCN5 | |
| Interaction | MIER1 interactions | 3.30e-04 | 80 | 34 | 3 | int:MIER1 | |
| Interaction | NR2C1 interactions | 3.81e-04 | 84 | 34 | 3 | int:NR2C1 | |
| Cytoband | 8p23.1 | 5.85e-03 | 154 | 34 | 2 | 8p23.1 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 8.21e-09 | 4 | 24 | 3 | 989 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 6.05e-05 | 9 | 24 | 2 | 1306 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.11e-04 | 12 | 24 | 2 | 1305 | |
| GeneFamily | Defensins, alpha | 1.11e-04 | 12 | 24 | 2 | 502 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.11e-04 | 12 | 24 | 2 | 1243 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.35e-02 | 134 | 24 | 2 | 861 | |
| CoexpressionAtlas | bone marrow | 6.25e-06 | 292 | 34 | 6 | bone marrow | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.15e-08 | 126 | 34 | 5 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.90e-06 | 162 | 34 | 4 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.90e-06 | 162 | 34 | 4 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | Monocytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.09e-06 | 49 | 34 | 3 | bf67f5dee042fd680c661db637fde715e48b14c5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-06 | 173 | 34 | 4 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Myelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 185 | 34 | 4 | 92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 190 | 34 | 4 | cb62ece5929896dfba30a4f563c6ba5a5712b71e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-05 | 190 | 34 | 4 | fedd266198d294d8da8c9e217e5e0cb8b2e1b566 | |
| ToppCell | COVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class | 1.29e-05 | 190 | 34 | 4 | 8a81cb90273c361e9fdfaa0a31806da253fa1388 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-05 | 192 | 34 | 4 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.43e-05 | 195 | 34 | 4 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.46e-05 | 196 | 34 | 4 | 646a8d47dddffdfd2d8a62245ea6cd49f9510a1a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-05 | 197 | 34 | 4 | cfc9decbfa9ebadafda8b620ec529d3fcdd15dcd | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.55e-05 | 199 | 34 | 4 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | 51be0e3a91d1f25454b56d55ef6342ef8e8df4e8 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.55e-05 | 199 | 34 | 4 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-04 | 126 | 34 | 3 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 1.23e-04 | 127 | 34 | 3 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-04 | 128 | 34 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-04 | 128 | 34 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-04 | 129 | 34 | 3 | 5578a9ef85706ab6a204ff31716e781ec3893b75 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-04 | 130 | 34 | 3 | 124f76067a2d4448ce06158a769d0d11b0297110 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-04 | 130 | 34 | 3 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-04 | 131 | 34 | 3 | fdec4e31ffeb02615ccb7097758a8218dd1f8c1c | |
| ToppCell | Control-Myeloid_G|Control / Disease group, lineage and cell class | 1.35e-04 | 131 | 34 | 3 | d5a53431f1f1b283fb9338b8561e6381f0227c62 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 133 | 34 | 3 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 133 | 34 | 3 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 1.71e-04 | 142 | 34 | 3 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 142 | 34 | 3 | bf3537bec0eca9f90c00df9ba840c371f1c9856e | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-04 | 143 | 34 | 3 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 143 | 34 | 3 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-04 | 143 | 34 | 3 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | Myeloid-E_(Neutrophils)|World / shred on cell class and cell subclass (v4) | 1.82e-04 | 145 | 34 | 3 | 6ae7dbc62116b4d0610fb55703679488e8da4733 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-04 | 148 | 34 | 3 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | 2a2a5673ce4f376e7b25f2bc8127fb7e260f37af | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | c9f02ec62a658a751e591699f9395fe597e22a2e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | c9334f319a0c943268e54b6f0c9446736172c3a9 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 2.01e-04 | 150 | 34 | 3 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | Monocytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-04 | 150 | 34 | 3 | b580b06795973fec16ea6f7f5b6b9d580bf7fcf5 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-04 | 153 | 34 | 3 | ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-04 | 153 | 34 | 3 | 9dba38574908f31a1194b8a339868f5e4be1be71 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 154 | 34 | 3 | ad6cfd7fc02f4201863dc8e12e353395c86c5fdb | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-04 | 154 | 34 | 3 | f92d83c5f8b532fe5624f1cd352632f543d96ea9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 155 | 34 | 3 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 155 | 34 | 3 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 155 | 34 | 3 | 3f31f3c37eb40d5467def8506e349fa4b4695833 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-04 | 157 | 34 | 3 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-04 | 158 | 34 | 3 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 2.53e-04 | 162 | 34 | 3 | 12bd0b99aee13da60d0684a5e2a705824db1899c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 163 | 34 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 163 | 34 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 165 | 34 | 3 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | facs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 166 | 34 | 3 | 9116be2805c34881debb999d8417e43832fcf2f2 | |
| ToppCell | LAM-Myeloid-Mast|LAM / Condition, Lineage and Cell class | 2.71e-04 | 166 | 34 | 3 | e0ce973cc2a091b832c67b3b32dc153379daa2ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 166 | 34 | 3 | 6a65dff1333f39ec8c584e6df04b8c1e7f1c8946 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 2.71e-04 | 166 | 34 | 3 | 9788486582cc2c5f28b9ea015e235732f9fefb1e | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 166 | 34 | 3 | 5c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 168 | 34 | 3 | b0376e3687fa85f091654196403eecedc219d0cd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 168 | 34 | 3 | 937332580a522826b820e0b09080013f19f58479 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.81e-04 | 168 | 34 | 3 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 170 | 34 | 3 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-04 | 170 | 34 | 3 | bca78719c17355772ad6c53ee75e459faf1d089f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-04 | 170 | 34 | 3 | 40d863554ec98ae43f76511c1112859688846613 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 171 | 34 | 3 | b3ea26d181f91ea07074f403e7dca9b6b671b1a2 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 171 | 34 | 3 | d6ae456e88ec49a8609a5e5e3af9f51921e66744 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 171 | 34 | 3 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 172 | 34 | 3 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-04 | 172 | 34 | 3 | eaba10a4d4eaab42ad2e2da65ebb20b50edaf815 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 172 | 34 | 3 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 172 | 34 | 3 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 173 | 34 | 3 | b2c55084ef6dac0e329c2e65c24cfe0045859c30 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 173 | 34 | 3 | b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 173 | 34 | 3 | 120dd20e8a71f9169a1596b6171df7aa0b96dd15 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 34 | 3 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 34 | 3 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 03cee3d24bc433e91a867ce951589de64a0538af | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.11e-04 | 174 | 34 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | NS-control-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.11e-04 | 174 | 34 | 3 | 2d1f5c17b1551f32f49618ec1bf68eafbfd02ace | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 174 | 34 | 3 | 36080fa12497faa752ff07ae52cd3864053eafef | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 174 | 34 | 3 | ce9bdd02dc8eb45ba9c1481619c0089b465e6442 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-04 | 177 | 34 | 3 | 4a222234ca6cf28a34205c4bd675cd49d92b5b2e | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 5d70fe2b0592362d664b3b4c84eb450ec2335957 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 48bcf603ec9593eedd81f3831cf9fde89fad368f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 177 | 34 | 3 | ed44b1bf2ffae97f94e944d1b6060d5163eba6a6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-04 | 177 | 34 | 3 | 15553c7cd7826c80086daa76af4224f32dde53a6 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-04 | 178 | 34 | 3 | c6704fcd21a9d2fe45679a1d998f04213b3bf224 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.44e-04 | 180 | 34 | 3 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.44e-04 | 180 | 34 | 3 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 181 | 34 | 3 | 08bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59 | |
| ToppCell | Monocytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.50e-04 | 181 | 34 | 3 | d8b98c3d9bef026a0a35948219027f27718ffbee | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.50e-04 | 181 | 34 | 3 | 3457c1d431db4282be5a6243119e48960748ede7 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.55e-04 | 182 | 34 | 3 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-04 | 182 | 34 | 3 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-04 | 183 | 34 | 3 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.61e-04 | 183 | 34 | 3 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| Drug | Vorinostat | 3.04e-08 | 5 | 34 | 3 | DB02546 | |
| Drug | AC1NRC7S | 3.60e-08 | 23 | 34 | 4 | CID005288867 | |
| Drug | CI-994 | 3.62e-07 | 10 | 34 | 3 | CID000002746 | |
| Drug | 15-deoxy-delta(12,14)-prostaglandin J2 | 7.14e-07 | 114 | 34 | 5 | ctd:C097240 | |
| Drug | Fingolimod Hydrochloride | 1.34e-06 | 55 | 34 | 4 | ctd:D000068876 | |
| Drug | AC1NV99J | 1.68e-06 | 16 | 34 | 3 | CID005474719 | |
| Drug | polyphenon E | 2.04e-06 | 17 | 34 | 3 | ctd:C472086 | |
| Drug | Rodeo | 2.04e-06 | 17 | 34 | 3 | CID000038078 | |
| Drug | 2-methoxyethoxy)acetic acid | 2.16e-06 | 2 | 34 | 2 | CID000027642 | |
| Drug | p-sulfobenzyl alcohol | 2.16e-06 | 2 | 34 | 2 | CID000441138 | |
| Drug | Pimelic Acids | 2.16e-06 | 2 | 34 | 2 | ctd:D010867 | |
| Drug | 1,2,5,6-tetramethylnaphthalene | 2.16e-06 | 2 | 34 | 2 | CID006427081 | |
| Drug | 1,4,5-trimethylnaphthalene | 2.16e-06 | 2 | 34 | 2 | CID000016478 | |
| Drug | AC1L1EXH | 2.44e-06 | 18 | 34 | 3 | CID000002992 | |
| Drug | NSC3852 | 3.41e-06 | 20 | 34 | 3 | CID000019103 | |
| Drug | AC1L1EA5 | 6.03e-06 | 24 | 34 | 3 | CID000002706 | |
| Drug | trapoxin B | 6.49e-06 | 3 | 34 | 2 | ctd:C067071 | |
| Drug | 4-ethylbenzoate | 6.49e-06 | 3 | 34 | 2 | CID000012086 | |
| Drug | UF010 compound | 6.84e-06 | 25 | 34 | 3 | ctd:C000602704 | |
| Drug | topanol A | 1.30e-05 | 4 | 34 | 2 | CID000015884 | |
| Drug | 4-fluorobenzoyl chloride | 1.30e-05 | 4 | 34 | 2 | CID000067879 | |
| Drug | xenognosin B | 1.30e-05 | 4 | 34 | 2 | CID005280551 | |
| Drug | AC1L3OZP | 1.30e-05 | 4 | 34 | 2 | CID000092862 | |
| Drug | sperabillin A | 1.30e-05 | 4 | 34 | 2 | CID006441177 | |
| Drug | AC1L1G8B | 1.47e-05 | 32 | 34 | 3 | CID000003571 | |
| Drug | triglyme | 1.47e-05 | 32 | 34 | 3 | CID000008189 | |
| Drug | AC1OC6D1 | 1.71e-05 | 104 | 34 | 4 | CID006368594 | |
| Drug | AC1OAH4D | 2.10e-05 | 36 | 34 | 3 | CID006857719 | |
| Drug | AC1O5T5C | 2.16e-05 | 5 | 34 | 2 | CID006440182 | |
| Drug | dipropylacetal | 2.16e-05 | 5 | 34 | 2 | CID000066929 | |
| Drug | 4-carbethoxyhexafluorobutyryl chloride | 2.16e-05 | 5 | 34 | 2 | CID000161251 | |
| Drug | tanshinone | 2.64e-05 | 116 | 34 | 4 | ctd:C021751 | |
| Drug | BT-B | 2.87e-05 | 243 | 34 | 5 | CID000081462 | |
| Drug | flufenacet | 3.23e-05 | 6 | 34 | 2 | CID000086429 | |
| Drug | testosterone acetate | 3.23e-05 | 6 | 34 | 2 | CID000092145 | |
| Drug | AR-L57 | 3.23e-05 | 6 | 34 | 2 | CID000156890 | |
| Drug | TMSI | 4.52e-05 | 7 | 34 | 2 | CID000028925 | |
| Drug | 4-sulfobenzoate | 4.52e-05 | 7 | 34 | 2 | CID000069469 | |
| Drug | 4-amino-5-chloro-2-methoxybenzoate | 4.52e-05 | 7 | 34 | 2 | CID000081626 | |
| Drug | 3-bromopropionate | 4.52e-05 | 7 | 34 | 2 | CID000011553 | |
| Drug | AC 695 | 4.72e-05 | 47 | 34 | 3 | CID000004885 | |
| Drug | Taifun | 6.03e-05 | 8 | 34 | 2 | CID000047937 | |
| Drug | AC1L2CQC | 6.03e-05 | 8 | 34 | 2 | CID000018756 | |
| Drug | 2,6-DMN | 6.03e-05 | 8 | 34 | 2 | CID000011387 | |
| Drug | traumatin | 6.03e-05 | 8 | 34 | 2 | CID005312889 | |
| Drug | NSC-364372 | 7.26e-05 | 484 | 34 | 6 | CID000435143 | |
| Drug | myxoxanthophyll | 7.74e-05 | 9 | 34 | 2 | CID005319993 | |
| Drug | ginsenoside Rh2 | 7.74e-05 | 9 | 34 | 2 | ctd:C055305 | |
| Drug | I82-2 | 7.74e-05 | 9 | 34 | 2 | CID000007899 | |
| Drug | dithiopyr | 7.74e-05 | 9 | 34 | 2 | CID000091757 | |
| Drug | BuPdG | 7.74e-05 | 9 | 34 | 2 | CID003036311 | |
| Drug | trapoxin | 8.88e-05 | 58 | 34 | 3 | CID000121875 | |
| Drug | SNAG | 9.34e-05 | 59 | 34 | 3 | CID000177324 | |
| Drug | S 14297 | 9.67e-05 | 10 | 34 | 2 | CID000115007 | |
| Drug | 1-methylnaphthalene | 9.67e-05 | 10 | 34 | 2 | CID000007002 | |
| Drug | AC1Q4I4X | 9.67e-05 | 10 | 34 | 2 | CID000122085 | |
| Drug | N-methylpyrrolidine | 9.67e-05 | 10 | 34 | 2 | CID000008454 | |
| Drug | 1,3-glyceryl dinitrate | 9.67e-05 | 10 | 34 | 2 | CID000012200 | |
| Drug | vorinostat | 9.68e-05 | 314 | 34 | 5 | CID000005311 | |
| Drug | DB08184 | 1.09e-04 | 167 | 34 | 4 | CID009547945 | |
| Drug | AC1L3UED | 1.18e-04 | 11 | 34 | 2 | CID000122332 | |
| Drug | bornane | 1.18e-04 | 11 | 34 | 2 | CID000092108 | |
| Drug | AC1L9IH9 | 1.18e-04 | 11 | 34 | 2 | CID000445730 | |
| Drug | iodosulpride | 1.42e-04 | 12 | 34 | 2 | CID000122245 | |
| Drug | tetrahydronaphthalen-1-ol | 1.42e-04 | 12 | 34 | 2 | CID000001240 | |
| Drug | Uh 232 | 1.42e-04 | 12 | 34 | 2 | CID000123696 | |
| Drug | P 14 | 1.67e-04 | 13 | 34 | 2 | CID000056603 | |
| Drug | 4-tert-butylcatechol | 1.67e-04 | 13 | 34 | 2 | CID000007381 | |
| Drug | rhodotorulic acid | 1.67e-04 | 13 | 34 | 2 | CID000029337 | |
| Drug | dimethyltin | 1.67e-04 | 13 | 34 | 2 | CID000031651 | |
| Drug | fuculose | 1.67e-04 | 13 | 34 | 2 | CID000000841 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 1.79e-04 | 190 | 34 | 4 | 6199_UP | |
| Drug | Go 6976 | 1.91e-04 | 75 | 34 | 3 | ctd:C081021 | |
| Drug | AC1L9LVP | 1.95e-04 | 14 | 34 | 2 | CID000448357 | |
| Drug | dinitroglycerol | 1.95e-04 | 14 | 34 | 2 | CID000079076 | |
| Drug | 6-.beta.-Naltrexol | 1.95e-04 | 14 | 34 | 2 | CID000631219 | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1856_UP | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 3090_UP | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 2.10e-04 | 198 | 34 | 4 | 881_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 3576_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 2095_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 2731_DN | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.18e-04 | 200 | 34 | 4 | 5700_UP | |
| Drug | nafadotride | 2.25e-04 | 15 | 34 | 2 | CID003408722 | |
| Drug | AC1L2RBE | 2.25e-04 | 15 | 34 | 2 | CID000101675 | |
| Drug | 13-HpOTrE | 2.25e-04 | 15 | 34 | 2 | CID005282866 | |
| Drug | TAM67 | 2.25e-04 | 15 | 34 | 2 | CID000005626 | |
| Drug | pentafluorobenzoyl chloride | 2.56e-04 | 16 | 34 | 2 | CID000075256 | |
| Drug | 3-hydroxy-9-methoxypterocarpan | 2.56e-04 | 16 | 34 | 2 | CID000073067 | |
| Drug | 3-HPA | 2.90e-04 | 17 | 34 | 2 | CID000013401 | |
| Drug | S 15535 | 2.90e-04 | 17 | 34 | 2 | CID000132787 | |
| Drug | PFPA | 3.26e-04 | 18 | 34 | 2 | CID000067742 | |
| Drug | hexamethyldisiloxane | 3.26e-04 | 18 | 34 | 2 | CID000024764 | |
| Drug | naphtho(1,2-b)furan-4,5-dione | 3.26e-04 | 18 | 34 | 2 | ctd:C073873 | |
| Drug | chondroitin sulfate | 3.46e-04 | 413 | 34 | 5 | CID000024766 | |
| Drug | AC1O4WK7 | 3.64e-04 | 19 | 34 | 2 | CID006420129 | |
| Drug | Gp54 | 3.64e-04 | 19 | 34 | 2 | CID003002999 | |
| Drug | metrizamide | 4.04e-04 | 20 | 34 | 2 | CID000035734 | |
| Drug | 3-methylcatechol | 4.20e-04 | 98 | 34 | 3 | CID000000340 | |
| Drug | trifluoroacetamide | 4.47e-04 | 21 | 34 | 2 | CID000067717 | |
| Disease | pulmonary hypertension (is_marker_for) | 6.91e-07 | 64 | 32 | 4 | DOID:6432 (is_marker_for) | |
| Disease | toll-like receptor 2 measurement | 6.83e-06 | 4 | 32 | 2 | EFO_0020777 | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 1.70e-05 | 6 | 32 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | colorectal cancer (is_marker_for) | 2.47e-05 | 157 | 32 | 4 | DOID:9256 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.00e-05 | 61 | 32 | 3 | DOID:3587 (is_marker_for) | |
| Disease | alopecia areata (is_marker_for) | 5.10e-05 | 10 | 32 | 2 | DOID:986 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 6.57e-05 | 72 | 32 | 3 | DOID:9744 (is_marker_for) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.99e-05 | 80 | 32 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | thrombosis (is_implicated_in) | 1.19e-04 | 15 | 32 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | endometriosis (biomarker_via_orthology) | 1.35e-04 | 16 | 32 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | glaucoma (is_marker_for) | 2.14e-04 | 20 | 32 | 2 | DOID:1686 (is_marker_for) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.14e-04 | 20 | 32 | 2 | DOID:3328 (is_marker_for) | |
| Disease | prostate carcinoma (is_marker_for) | 2.84e-04 | 23 | 32 | 2 | DOID:10286 (is_marker_for) | |
| Disease | Squamous cell carcinoma | 3.29e-04 | 124 | 32 | 3 | C0007137 | |
| Disease | colon adenocarcinoma (is_marker_for) | 3.37e-04 | 25 | 32 | 2 | DOID:234 (is_marker_for) | |
| Disease | ovarian carcinoma (is_marker_for) | 4.23e-04 | 28 | 32 | 2 | DOID:4001 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 4.23e-04 | 28 | 32 | 2 | DOID:3083 (biomarker_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 4.89e-04 | 142 | 32 | 3 | DOID:10534 (is_marker_for) | |
| Disease | Chronic Obstructive Airway Disease | 5.89e-04 | 33 | 32 | 2 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 5.89e-04 | 33 | 32 | 2 | C1527303 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 6.25e-04 | 34 | 32 | 2 | DOID:9952 (is_marker_for) | |
| Disease | endometrial carcinoma (is_marker_for) | 6.25e-04 | 34 | 32 | 2 | DOID:2871 (is_marker_for) | |
| Disease | neutrophil measurement | 9.26e-04 | 177 | 32 | 3 | EFO_0803548 | |
| Disease | Calcinosis | 9.55e-04 | 42 | 32 | 2 | C0006663 | |
| Disease | Microcalcification | 9.55e-04 | 42 | 32 | 2 | C0521174 | |
| Disease | Tumoral calcinosis | 9.55e-04 | 42 | 32 | 2 | C0263628 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 9.55e-04 | 42 | 32 | 2 | DOID:8991 (is_marker_for) | |
| Disease | glioblastoma (is_marker_for) | 1.05e-03 | 44 | 32 | 2 | DOID:3068 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSAYRSNQWRYRGRC | 396 | Q96KE9 | |
| CAYRSNQWRYRGRCD | 381 | Q9Y2F9 | |
| ERRAYQWCREYLGGA | 46 | Q9Y259 | |
| PRWYCSGSNRAYRHG | 121 | O60674 | |
| QYVYRCGSAQGWSRR | 106 | Q6ZNF0 | |
| GPQHAGNYRCRYRSW | 461 | P04217 | |
| GRSDGYRWCATTANY | 306 | P14780 | |
| ARLWRALYGAFGRCY | 271 | Q5T3U5 | |
| SRYGRYVATQWCVAV | 186 | A6NDP7 | |
| GGYTIRNVARCWTYE | 301 | Q13547 | |
| NVSGIYRCYGWYNRS | 186 | P24071 | |
| GNSRGNTWARRNLYY | 116 | P07098 | |
| YWAVDRCYTGSGRVA | 1171 | O94915 | |
| NNYARYRRTWAGCAG | 331 | Q8TDF6 | |
| AANVGRVVNSWYRYR | 171 | Q96KN4 | |
| RGYNVTYWREGSQRK | 846 | P32004 | |
| GIYGCRWKRYQRSHD | 21 | Q8WTR4 | |
| RGYYVFDSRWNRLRC | 531 | O15265 | |
| GGYTVRNVARCWTYE | 296 | O15379 | |
| YRRYQDWGATNARVG | 151 | P07320 | |
| GERRYGTCIYQGRLW | 76 | P59665 | |
| GERRYGTCIYQGRLW | 76 | P59666 | |
| RYYRCDRNLVWNAGA | 76 | P12109 | |
| DWVYGYRGRDSRSNL | 251 | Q32P44 | |
| GTQRCWNLYGKCRYR | 21 | Q8N688 | |
| GGGYTIRNVARCWTY | 301 | Q92769 | |
| LCAGRWTYGRYIRSA | 691 | O60716 | |
| GNCSSALRWLGRYYC | 186 | P02790 | |
| RYRGSYWRTVRACLG | 76 | Q86WV6 | |
| WSVQYRYDGVGRRAS | 2296 | Q9NT68 | |
| WPYNYQGCRSACRVI | 306 | O75829 | |
| CRRRYYEEGWLATGN | 36 | Q9NRJ4 | |
| QGYPTRRARYQWVRC | 26 | P10124 | |
| GEGIYARYNCRDAVW | 1141 | P35573 |